Osteoarthritis Management: Bridging the Gap Between Evidence-Based Guidelines and Real-World Practices

Recent research highlights a significant gap between osteoarthritis treatment guidelines and real-world practices, emphasizing the need for better adherence to evidence-based interventions like weight management and patient education.
Osteoarthritis is a common and debilitating condition that causes chronic joint pain, often impacting daily life and overall quality of life. The European Alliance of Associations for Rheumatology (EULAR) has developed comprehensive clinical guidelines for managing osteoarthritis, especially focusing on the hand, hip, and knee joints. These guidelines emphasize the importance of evidence-based interventions such as patient education, weight management, physical therapy, and appropriate medication use.
Despite clear recommendations, realities in clinical practice often diverge from these guidelines. Recent data presented at the 2025 EULAR Congress from the Austrian BLOAR registry shed light on this discrepancy. The registry, which analyzed the healthcare usage patterns of 1,716 patients with osteoarthritis, revealed that most patients are being treated mainly for knee osteoarthritis—over half of the cases—with significant proportions also suffering from hand and hip osteoarthritis.
The findings indicate that over 80% of patients suffer from moderate to severe disease, with many experiencing substantial pain during activity. Notably, while a high percentage of patients received consultations and physical therapy—either active (functional therapy) or passive modalities—the implementation of weight management strategies remains drastically low, with only about 10% receiving dietary or weight-loss support, despite strong guidelines advocating for such interventions.
Additionally, many patients resort to supplements like vitamins and plant-based products, which are not recommended by evidence-based guidelines. This reliance on non-evidence-based treatments highlights a significant gap in the application of proven therapies.
Valentina Schmolik and colleagues emphasize the need for increased awareness among healthcare providers regarding the importance of evidence-based management of osteoarthritis. Bridging the gap between guidelines and practice can lead to better patient outcomes. Efforts should focus on educating both clinicians and patients about effective strategies, including weight control and proper medication use, while addressing misconceptions that lead to the popularity of unproven treatments.
Improving adherence to clinical guidelines is essential for optimizing care and reducing unnecessary, non-evidence-based practices. Such alignment can significantly enhance the quality of life for individuals suffering from osteoarthritis and ensure healthcare resources are utilized effectively.
Source: https://medicalxpress.com/news/2025-06-osteoarthritis-evidence-based-therapies.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Targeting Astrocytic GABA Production to Promote Spinal Cord Repair and Neuronal Regeneration
A groundbreaking study reveals that inhibiting GABA production in astrocytes can promote spinal cord repair and neuronal regeneration, offering new hope for injury recovery. Researchers identify the MAOB enzyme as a key target, with promising results in animal models and safety validated in clinical trials.
Limited Effectiveness of Emergency Health Messaging on Social Media Platforms
A recent study highlights the limitations of social media in emergency health communication, emphasizing the need for more interactive and multilingual approaches during health crises.
New Guidelines for Clinical Homologous Recombination Deficiency Testing Published
The Association for Molecular Pathology has published new best practice guidelines for homologous recombination deficiency testing, aiming to standardize assays and enhance cancer diagnosis and treatment outcomes.
RNA Isoform Atlas Enhances Understanding of Cardiovascular Disease
A new RNA isoform atlas developed by Northwestern scientists provides critical insights into gene splicing variations in healthy and diseased hearts, paving the way for improved cardiovascular disease diagnosis and treatment.



